CATALYST PHARMACEUTICALS INC (CPRX) — insider trading
Health Care · NASDAQ
CATALYST PHARMACEUTICALS INC (CPRX) has 32 reported SEC Form 4 insider transactions in our data (latest 2026-06-03).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Andrews William T. | Officer (Chief Medical Officer) | Shares withheld for taxes / exercise cost | 743 | — | — | Form 4 |
| 2026-06-03 | Andrews William T. | Officer (Chief Medical Officer) | Option exercise / conversion | 3,052 | — | — | Form 4 |
| 2026-02-17 | Russo Gregg | Officer (Chief HR Officer) | Option exercise / conversion (derivative) | 687 | $0.00 | $0 | Form 4 |
| 2026-02-17 | Russo Gregg | Officer (Chief HR Officer) | Shares withheld for taxes / exercise cost | 211 | — | — | Form 4 |
| 2026-02-17 | Russo Gregg | Officer (Chief HR Officer) | Option exercise / conversion | 687 | — | — | Form 4 |
| 2026-01-05 | Daly Richard J | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 42,105 | $0.00 | $0 | Form 4 |
| 2026-01-05 | Daly Richard J | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 10,577 | — | — | Form 4 |
| 2026-01-05 | Daly Richard J | Director, Officer (President and CEO) | Option exercise / conversion | 42,105 | — | — | Form 4 |
| 2026-01-05 | Kalb Michael Wayne | Officer (Executive Vice President & CFO) | Option exercise / conversion (derivative) | 7,139 | $0.00 | $0 | Form 4 |
| 2026-01-05 | Kalb Michael Wayne | Officer (Executive Vice President & CFO) | Shares withheld for taxes / exercise cost | 2,080 | — | — | Form 4 |
| 2026-01-05 | Kalb Michael Wayne | Officer (Executive Vice President & CFO) | Option exercise / conversion | 7,139 | — | — | Form 4 |
| 2025-12-29 | Daly Richard J | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 1,334 | $0.00 | $0 | Form 4 |
| 2025-12-29 | Daly Richard J | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 524 | — | — | Form 4 |
| 2025-12-29 | Daly Richard J | Director, Officer (President and CEO) | Option exercise / conversion | 1,334 | — | — | Form 4 |
| 2025-12-29 | MCENANY PATRICK J | Director, Other | Option exercise / conversion (derivative) | 26,334 | $0.00 | $0 | Form 4 |
| 2025-12-29 | MCENANY PATRICK J | Director, Other | Shares withheld for taxes / exercise cost | 6,786 | — | — | Form 4 |
| 2025-12-29 | MCENANY PATRICK J | Director, Other | Option exercise / conversion | 26,334 | — | — | Form 4 |
| 2025-12-29 | Harper Molly | Director | Option exercise / conversion (derivative) | 1,334 | $0.00 | $0 | Form 4 |
| 2025-12-29 | Harper Molly | Director | Option exercise / conversion | 1,334 | — | — | Form 4 |
| 2025-12-29 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Option exercise / conversion (derivative) | 14,000 | $0.00 | $0 | Form 4 |
| 2025-12-29 | Miller Steve | Officer (Chief Op. & Scientific Officer) | Option exercise / conversion | 14,000 | — | — | Form 4 |
| 2025-12-29 | Sundaram Preethi | Officer (Chief Strategy Officer) | Option exercise / conversion (derivative) | 6,667 | $0.00 | $0 | Form 4 |
| 2025-12-29 | Sundaram Preethi | Officer (Chief Strategy Officer) | Shares withheld for taxes / exercise cost | 2,369 | — | — | Form 4 |
| 2025-12-29 | Sundaram Preethi | Officer (Chief Strategy Officer) | Option exercise / conversion | 6,667 | — | — | Form 4 |
| 2025-12-29 | Tierney David S | Director | Option exercise / conversion (derivative) | 1,334 | $0.00 | $0 | Form 4 |
| 2025-12-29 | Tierney David S | Director | Option exercise / conversion | 1,334 | — | — | Form 4 |
| 2025-12-29 | Elsbernd Brian | Officer (Chief Compliance/Legal Officer) | Option exercise / conversion (derivative) | 6,667 | $0.00 | $0 | Form 4 |
| 2025-12-29 | Elsbernd Brian | Officer (Chief Compliance/Legal Officer) | Shares withheld for taxes / exercise cost | 2,623 | — | — | Form 4 |
| 2025-12-29 | Elsbernd Brian | Officer (Chief Compliance/Legal Officer) | Option exercise / conversion | 6,667 | — | — | Form 4 |
| 2025-12-29 | DENKHAUS DONALD A | Director | Option exercise / conversion (derivative) | 1,334 | $0.00 | $0 | Form 4 |
| 2025-12-29 | DENKHAUS DONALD A | Director | Option exercise / conversion | 1,334 | — | — | Form 4 |
| 2025-06-03 | Andrews William T. | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 3,052 | $0.00 | $0 | Form 4 |
Ask the chat about CPRX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CATALYST PHARMACEUTICALS INC (CPRX).
Last updated 2026-06-03 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.